Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Medlive Technology Co., Ltd. ( (HK:2192) ) just unveiled an update.
Medlive Technology Co., Ltd. has issued a supplemental announcement detailing its Audit Committee’s assessment of Deloitte as the proposed new auditor, following an earlier notice of auditor change. The committee highlighted Deloitte’s Big Four status, its governance structure, quality assurance mechanisms, and the experienced engagement team that will serve the company.
The Audit Committee also emphasized Deloitte’s compliance with Hong Kong’s professional ethical standards and its own global principles of business conduct, including independence, transparency, and high audit quality. In addition, it cited Deloitte’s sizable life sciences and healthcare practice and extensive work with major global players in the sector, concluding that Deloitte has the integrity, independence, and industry expertise required to support Medlive’s audit needs.
More about Medlive Technology Co., Ltd.
Medlive Technology Co., Ltd. is a Cayman Islands-incorporated company listed in Hong Kong under stock code 2192. It operates in the life sciences and healthcare sector, where it relies on external auditors with strong industry expertise to support its financial reporting and governance framework.
Average Trading Volume: 2,317,116
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.39B
For a thorough assessment of 2192 stock, go to TipRanks’ Stock Analysis page.